Chemical Compound
Lisdexamfetamine dimesylate
CAS Registry Number
608137-33-3
Primary Record
Lisdexamfetamine dimesylate
- In stock
- 4,013 g
- Purity
- 98.8 %
- CAS
- 608137-33-3
Compound Identifiers & Properties
- CAS
- 608137-33-3
- PubChem CID
- 11597697
- SMILES
- C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O
- Canonical SMILES
- CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN
Names & Synonyms
- Lisdexamfetamine dimesylate
- Vyvanse
- Tyvense
- Lisdexamfetamine mesilate
- elvanse
- Venvanse
- Elvanse adult
- Lisdexamfetamine mesylate
- Lys-Amp
- lis-dexamfetamine dimesylate
- Lys-d-Amp
- NRP-104
- SJT761GEGS
- Elvanse (TN)
- Vyvanse (TN)
- SPD489
- UNII-SJT761GEGS
- ARYNTA
- Lisdexamfetamine dimesilate
- Lisdexamphetamine dimesilate
- NRP104
- NRP 104
- RefChem:57033
- 608137-33-3
- SPD-489
- Lisdexamphetamine Dimesylate
- Dimesylate, Lisdexamfetamine
- Lis dexamfetamine Dimesylate
- Lisdexamfetamine dimethanesulfonate
- Dimesylate, Lis-dexamfetamine
- Lisdexamfetamine dimesylate [USAN]
- SCHEMBL678421
- DTXSID60209653
- L-Lysine-d-amphetamine dimesylate
- SPD 489
- CETWSOHVEGTIBR-FORAGAHYSA-N
- CHEMBL1201178
- Lisdexamfetamine mesilate (JAN)
- CTK5B2291
- DTXCID10132144
- C17H33N3O7S2
- Lisdexamfetamine dimesylate (USAN)
- Lisdexamfetamine dimesylate capsules
- Lisdexamfetamine dimesylate solution
- BCP24044
- AKOS030254940
- LISDEXAMFETAMINE MESILATE [JAN]
- CID11597697
- LISDEXAMFETAMINE MESILATE [MART.]
- AN-27750
- FL162437
- LISDEXAMFETAMINE MESILATE [WHO-DD]
- LISDEXAMFETAMINE DIMESYLATE [VANDF]
- LS-186600
- NS00076353
- D04747
- LISDEXAMFETAMINE DIMETHANESULFONATE [MI]
- LISDEXAMFETAMINE DIMESYLATE [ORANGE BOOK]
- 137L333
- 2-(2-Aminothiazole-4-yl)-2-hydroxyiminoacetic acid
- A1034459
- (2S)-2,6-DIAMINO-N-[(1S)-1-METHYL-2-PHENYLETHYL]HEXANAMIDE DIMETHANESULFONATE
- Q27289243
- (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid
- (S)-2,6-Diamino-N-((S)-1-phenylpropan-2-yl)hexanamide dimethanesulfonate
- LDX
- Methanesulfonic acid--N-[(2S)-1-phenylpropan-2-yl]-L-lysinamide (2/1)
- (2S)-2,6-DIAMINO-N-((1S)-1-METHYL-2-PHENYLETHYL)HEXANAMIDE DIMETHANESULPHONATE
- (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenyl-ethyl]hexanamide; methanesulfonic acid
- (2S)-2,6-diamino-N-[(1S)-1-methyl-2-phenyl-ethyl]hexanamide;methanesulfonic acid
- (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide,methanesulfonic acid
- -2,6-DIAMINO-N-[ -1-METHYL-2-PHENYLETHYL]HEXANAMIDEDIMETHANESULFONATE
- HEXANAMIDE, 2,6-DIAMINO-N-((1S)-1-METHYL-2-PHENYLETHYL), (2S), DIMETHANESULFONATE
- HEXANAMIDE, 2,6-DIAMINO-N-((1S)-1-METHYL-2-PHENYLETHYL), (2S), DIMETHANESULPHONATE
- Ldx;Lisdexamfetamine mesilate;Lisdexamfetamine mesylate;Nrp 104;Nrp-104;Spd 489
- 608137-32-2
- Hexanamide, 2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-, (2S)-, methanesulfonate (1:2); Hexanamide, 2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-, (2S)-, dimethanesulfonate (9CI); Lisdexamfetamine dimesylate; Lisdexamphetamine dimesylate; N-(L-Lysyl)-D-amphetamine dimesylate; NRP 104; SPD 489; Vyvanse; Lisdexamfetamine Dimesilate
- Lisdexamfetamine dimesylate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material